Neopharm was founded in 1941 under the direction of Dr. Leopold Goldschmidt, a pediatrician by profession, to represent Lederle Labs in Israel. Together with Zvi Sarel, Dr. Goldschmidt’s son in law, they received the marketing rights for the animal food additive “Aurofac”.
As Aurofac sales grew, Neopharm entered into new strategic representation alliances with additional companies, including the German pharmaceutical company Hermal (now operating under the name Almirall).
As Aurofac sales grew, Neopharm entered into new strategic representation alliances with additional companies, including the German pharmaceutical company Hermal (now operating under the name Almirall).
In 1980, David Fuhrer joined Neopharm to manage its chemical and veterinary departments. He rapidly succeeded in transforming both these departments into leaders in their respective fields. Under Mr. Fuhrer's directive, the company has established an independent distribution system to pharmacies in Israel, thus cementing its position as one of Israel's prominent pharmaceutical wholesalers.
In 2003, we acquired Eldan, which specializes in medical devices and equipment. This acquisition was followed by Neopharm’s purchase of Promedico in 2005. This move enabled Neopharm to offer logistic, distribution and third party logistic services to clients as well as access to pharmacy and a home care unit. In 2008, Genmedix became part of the Neopharm Group after its business was aquired from the multinational company Merck-Serono. Genmedix contributes to Neopharm’s capabilities in supply of non approved pharmaceuticals under special permits as well as generics.
Neopharm Israel was built on a legacy of over 75 years of excellence in pharmaceuticals marketing and distribution. Today, we are proud that our innovative therapies, services and personalized patient care play a major role in improving the lives of millions of people in Israel.
Neopharm Israel is recognized as one of the leading pharmaceuticals providers in Israel. Our strong local presence, combined with our well-established global network of business partnerships and collaborations, have catalyzed our continued growth and leadership position. Our deep understanding of reimbursement process have helped advance our consistent success in introducing pharmaceutical innovations to the local market.
Today, Neopharm Israel provides a one-stop-shop solution for international pharmaceutical companies seeking to successfully market their products in Israel. We help ensure that these products are made available to all patients in need while securing a solid revenue stream. Our comprehensive solutions are all created by our in-house teams of experts, including sales teams covering a wide variety of therapeutic segments, regulatory experts and in-house logistics center.